journal article·2018-11

Beyond Global Charge: Role of Amine Bulkiness and Protein Fingerprint on Nanoparticle–Cell Interaction

David Burnand, Ana Milosevic, Sandor Balog, Miguel Spuch‐Calvar, Barbara Rothen‐Rutishauser, Jörn Dengjel, Calum Kinnear, Thomas L. Moore, Alke Petri‐Fink

Small· Volume 14· Issue 46
Publisher page

Abstract

Abstract Amino groups presented on the surface of nanoparticles are well‐known to be a predominant factor in the formation of the protein corona and subsequent cellular uptake. However, the molecular mechanism underpinning this relationship is poorly defined. This study investigates how amine type and density affect the protein corona and cellular association of gold nanoparticles with cells in vitro. Four specific poly(vinyl alcohol‐co‐N‐vinylamine) copolymers are synthesized containing primary, secondary, or tertiary amines. Particle cellular association (i.e., cellular uptake and surface adsorption), as well as protein corona composition, are then investigated. It is found that the protein corona (as a consequence of “amine bulkiness”) and amine density are both important in dictating cellular association. By evaluating the nanoparticle surface chemistry and the protein fingerprint, proteins that are significant in mediating particle–cell association are identified. In particular, primary amines, when exposed on the polymer side chain, are strongly correlated with the presence of alpha‐2‐HS‐glycoprotein, and promote nanoparticle cellular association.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies · Protein Interaction Studies and Fluorescence Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Chemistry Department Université de Fribourg 1700 Fribourg Switzerland

Adolphe Merkle Institute Université de Fribourg 1700 Fribourg Switzerland

Department of Biology Université de Fribourg 1700 Fribourg Switzerland

School of Chemistry University of Melbourne Parkville 3010 Australia

Funding

Université de Fribourg · Adolphe Merkle Foundation · Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung · Australian Research Council

References (46)

Show source-provided references
1. 10.1186/1477-3155-12-510.1186/1477-3155-12-5 ↗
2. 10.1039/c3bm00137g10.1039/c3bm00137g ↗
3. 10.1021/acs.chemrev.7b0019410.1021/acs.chemrev.7b00194 ↗
4. 10.1039/c2nr33134a10.1039/c2nr33134a ↗
5. 10.1002/smll.20090115810.1002/smll.200901158 ↗
6. 10.1016/j.nano.2014.11.00410.1016/j.nano.2014.11.004 ↗
7. 10.1002/adma.20120229610.1002/adma.201202296 ↗
8. 10.1021/ja408241410.1021/ja4082414 ↗
9. 10.1021/nn406018q10.1021/nn406018q ↗
10. 10.3762/bjnano.6.8810.3762/bjnano.6.88 ↗
11. 10.1021/ar300039j10.1021/ar300039j ↗
12. 10.1002/anie.20140410010.1002/anie.201404100 ↗
13. 10.1016/j.jmmm.2014.09.00210.1016/j.jmmm.2014.09.002 ↗
14. 10.1016/S0003-2670(01)83825-310.1016/S0003-2670(01)83825-3 ↗
15. 10.1039/C1PY00429H10.1039/C1PY00429H ↗
16. 10.1016/j.eurpolymj.2013.07.00610.1016/j.eurpolymj.2013.07.006 ↗
17. 10.1098/rsta.2009.027310.1098/rsta.2009.0273 ↗
18. 10.1039/C5BM00187K10.1039/C5BM00187K ↗
19. 10.1039/C5PY01325A10.1039/C5PY01325A ↗
20. 10.1021/bi00846a02310.1021/bi00846a023 ↗
21. 10.1021/bi00088a04110.1021/bi00088a041 ↗
22. 10.1038/nmeth1008-85310.1038/nmeth1008-853 ↗
23. 10.1021/ac070208410.1021/ac0702084 ↗
24. 10.1039/C4NR06538G10.1039/C4NR06538G ↗
25. 10.1111/jace.1310810.1111/jace.13108 ↗
26. 10.1007/s13233-009-0111-210.1007/s13233-009-0111-2 ↗
27. 10.1021/nn200749610.1021/nn2007496 ↗
28. 10.1039/C4CS00487F10.1039/C4CS00487F ↗
29. 10.1021/acs.bioconjchem.6b0051410.1021/acs.bioconjchem.6b00514 ↗
30. 10.1016/j.actbio.2015.10.02910.1016/j.actbio.2015.10.029 ↗
31. 10.1186/1743-8977-11-1010.1186/1743-8977-11-10 ↗
32. 10.1016/S0168-3659(01)00368-610.1016/S0168-3659(01)00368-6 ↗
33. 10.1021/ma030027d10.1021/ma030027d ↗
34. 10.1016/j.biomaterials.2008.05.01510.1016/j.biomaterials.2008.05.015 ↗
35. 10.1039/C4RA03277B10.1039/C4RA03277B ↗
36. 10.1039/C4BM00264D10.1039/C4BM00264D ↗
37. 10.1002/dmrr.31510.1002/dmrr.315 ↗
38. 10.1002/cyto.a.1000510.1002/cyto.a.10005 ↗
39. 10.1016/j.ijpharm.2006.08.02510.1016/j.ijpharm.2006.08.025 ↗
40. 10.1074/jbc.M110.12892610.1074/jbc.M110.128926 ↗
41. 10.1016/S0378-5173(99)00432-910.1016/S0378-5173(99)00432-9 ↗
42. 10.1016/S1357-2725(99)00139-910.1016/S1357-2725(99)00139-9 ↗
43. 10.1371/journal.pone.009762710.1371/journal.pone.0097627 ↗
44. 10.1038/srep0502010.1038/srep05020 ↗
45. 10.1021/acs.biomac.5b0010810.1021/acs.biomac.5b00108 ↗
46. 10.1038/nnano.2013.18110.1038/nnano.2013.181 ↗